AI assistant
Neurogene Inc. — Director's Dealing 2015
Aug 12, 2015
33497_dirs_2015-08-12_a4c8c0c8-66f6-401d-b695-abf373bc64ff.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AQUINOX PHARMACEUTICALS, INC (AQXP)
CIK: 0001404644
Period of Report: 2015-08-10
Reporting Person: PFIZER INC (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-08-10 | Common Stock | S | 18.0000 | $29.0000 | Disposed | 1235312.0000 | Direct |
| 2015-08-10 | Common Stock | S | 2840.0000 | $41.2475 | Disposed | 1232472.0000 | Direct |
| 2015-08-10 | Common Stock | S | 2975.0000 | $28.4670 | Disposed | 1229497.0000 | Direct |
| 2015-08-10 | Common Stock | S | 3207.0000 | $35.6072 | Disposed | 1226290.0000 | Direct |
| 2015-08-10 | Common Stock | S | 6073.0000 | $40.2955 | Disposed | 1220217.0000 | Direct |
| 2015-08-10 | Common Stock | S | 8565.0000 | $27.3561 | Disposed | 1211652.0000 | Direct |
| 2015-08-10 | Common Stock | S | 8969.0000 | $21.4506 | Disposed | 1202683.0000 | Direct |
| 2015-08-10 | Common Stock | S | 9142.0000 | $39.5172 | Disposed | 1193541.0000 | Direct |
| 2015-08-10 | Common Stock | S | 9901.0000 | $37.2264 | Disposed | 1183640.0000 | Direct |
| 2015-08-10 | Common Stock | S | 10544.0000 | $36.3687 | Disposed | 1173096.0000 | Direct |
| 2015-08-10 | Common Stock | S | 11627.0000 | $38.4947 | Disposed | 1161469.0000 | Direct |
| 2015-08-10 | Common Stock | S | 12726.0000 | $25.3233 | Disposed | 1148743.0000 | Direct |
| 2015-08-10 | Common Stock | S | 13109.0000 | $26.3213 | Disposed | 1135634.0000 | Direct |
| 2015-08-10 | Common Stock | S | 25931.0000 | $20.3476 | Disposed | 1109703.0000 | Direct |
| 2015-08-10 | Common Stock | S | 31400.0000 | $24.3129 | Disposed | 1078303.0000 | Direct |
| 2015-08-10 | Common Stock | S | 44268.0000 | $22.5994 | Disposed | 1034035.0000 | Direct |
| 2015-08-10 | Common Stock | S | 58632.0000 | $23.4112 | Disposed | 975403.0000 | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.00 to $41.46, inclusive. The reporting person undertakes to provide to Aquinox Pharmaceuticals Inc., the "Issuer", any security holder of the Issuer, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes (1) through (16) to this Form 4.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.00 to $28.90, inclusive.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.25 to $35.94, inclusive.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.99, inclusive.
F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.90, inclusive.
F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.01 to $21.87, inclusive.
F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.00 to $39.99, inclusive.
F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.90, inclusive.
F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.99, inclusive.
F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.00 to $38.93, inclusive.
F11: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.99, inclusive.
F12: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.99, inclusive.
F13: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.82, inclusive.
F14: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.00 to $24.90, inclusive.
F15: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.00 to $22.98, inclusive.
F16: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.99, inclusive.